Effectiveness of percutaneous coronary intervention with drug‐eluting stents compared with bypass surgery in diabetics with multivessel coronary disease …

A Hakeem, N Garg, S Bhatti, N Rajpurohit… - Journal of the …, 2013 - Am Heart Assoc
Background Controversy persists regarding the optimal revascularization strategy for
diabetic patients with multivessel coronary artery disease (MVD). Coronary artery bypass …

Hybrid coronary revascularization versus off-pump coronary artery bypass grafting for the treatment of multivessel coronary artery disease

ME Halkos, TA Vassiliades, JS Douglas… - The Annals of Thoracic …, 2011 - Elsevier
BACKGROUND: Hybrid coronary revascularization (HCR) combines a minimally invasive (3-
cm anterolateral thoracotomy), sternal-sparing, off-pump left internal mammary artery–left …

Long-term comparison of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization: 5-year outcomes from the Asan Medical …

DW Park, YH Kim, HG Song, JM Ahn, J Oh… - Journal of the American …, 2011 - jacc.org
Objectives: We performed the long-term (5-year) follow-up of a large cohort of patients who
underwent drug-eluting stent (DES) or coronary artery bypass graft (CABG) surgery for …

Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease

AY Her, ES Shin, S Kim, B Kim, TH Kim… - Cardiovascular …, 2023 - Springer
Background Data on drug-coated balloon (DCB) treatment in the context of diabetes mellitus
(DM) and multivessel coronary artery disease (CAD) are limited. We aimed to investigate the …

Comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis

X Li, M Kong, D Jiang, A Dong - Interactive cardiovascular and …, 2014 - academic.oup.com
OBJECTIVES Although drug-eluting stents (DESs) reduce the rate of target vessel
revascularization compared with bare-metal stents, the results of DESs for patients with …

Coronary artery bypass grafting vs percutaneous coronary intervention in patients with diabetes

V Bianco, A Kilic, SR Mulukutla, TG Gleason… - Seminars in Thoracic …, 2021 - Elsevier
As percutaneous coronary intervention (PCI) continues to evolve, comparative outcomes for
PCI vs coronary artery bypass grafting (CABG) remain relevant in diabetic patients. All …

Glycosylated hemoglobin and coronary artery disease in patients without diabetes mellitus

M Verdoia, A Schaffer, E Cassetti, L Barbieri… - American journal of …, 2014 - Elsevier
Background Abnormal glucose metabolism is a major determinant of coronary artery
disease (CAD) and mortality in developed countries. Glycosylated hemoglobin (HbA1c) is a …

Coronary artery bypass grafting vs percutaneous coronary intervention in a 'real-world'setting: a comparative effectiveness study based on propensity score-matched …

D Fortuna, F Nicolini, P Guastaroba… - European Journal of …, 2013 - academic.oup.com
OBJECTIVES Most studies comparing coronary artery bypass grafting (CABG) and
percutaneous coronary interventions (PCI) showed that fewer patients who had undergone …

Modeling of in hospital mortality determinants in myocardial infarction patients, with and without type 2 diabetes, undergoing pharmaco-invasive strategy: the first …

A Ahmadi, H Soori, H Sajjadi - Diabetes research and clinical practice, 2015 - Elsevier
This study was conducted to compare the characteristics of patients, with and without
diabetes mellitus, presenting with myocardial infarction (MI) and treated with coronary artery …

One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic …

J Mieres, C Fernandez-Pereira, G Risau… - Cardiovascular …, 2012 - Elsevier
AIMS: Percutaneous coronary interventions (PCI) in patients with diabetes mellitus (DM) are
associated with a high incidence of coronary restenosis, myocardial infarction (MI) and …